Legal & General Group’s Takeda Pharmaceutical TAK Stock Holding History

Legal & General Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$697K	Hold	43,464	–	–	﹤0.01%	2306
2026 Q1	$774K	Sell	43,464 -64,382	-60%	-$1.13M	﹤0.01%	2224
2025 Q4	$1.68M	Sell	107,846 -15,000	-12%	-$214K	﹤0.01%	2043
2025 Q3	$1.8M	Sell	122,846 -13,869	-10%	-$206K	﹤0.01%	2025
2025 Q2	$2.11M	Hold	136,715	–	–	﹤0.01%	1944
2025 Q1	$2.03M	Hold	136,715	–	–	﹤0.01%	1915
2024 Q4	$1.81M	Sell	136,715 -7,551	-5%	-$104K	﹤0.01%	2012
2024 Q3	$2.05M	Hold	144,266	–	–	﹤0.01%	1955
2024 Q2	$1.87M	Buy	144,266 +5,281	+4%	+$69.9K	﹤0.01%	1973
2024 Q1	$1.93M	Hold	138,985	–	–	﹤0.01%	1957
2023 Q4	$1.98M	Hold	138,985	–	–	﹤0.01%	1960
2023 Q3	$2.16M	Hold	138,985	–	–	﹤0.01%	1866
2023 Q2	$2.18M	Hold	138,985	–	–	﹤0.01%	1887
2023 Q1	$2.29M	Hold	138,985	–	–	﹤0.01%	1827
2022 Q4	$2.17M	Hold	138,985	–	–	﹤0.01%	1843
2022 Q3	$1.8M	Hold	138,985	–	–	﹤0.01%	1910
2022 Q2	$1.95M	Hold	138,985	–	–	﹤0.01%	1898
2022 Q1	$1.99M	Hold	138,985	–	–	﹤0.01%	1983
2021 Q4	$1.89M	Hold	138,985	–	–	﹤0.01%	2053
2021 Q3	$2.28M	Hold	138,985	–	–	﹤0.01%	1963
2021 Q2	$2.34M	Hold	138,985	–	–	﹤0.01%	1900
2021 Q1	$2.54M	Hold	138,985	–	–	﹤0.01%	1874
2020 Q4	$2.53M	Hold	138,985	–	–	﹤0.01%	1787
2020 Q3	$2.48M	Hold	138,985	–	–	﹤0.01%	1675
2020 Q2	$2.49M	Hold	138,985	–	–	﹤0.01%	1641
2020 Q1	$2.11M	Sell	138,985 -19,799	-12%	-$359K	﹤0.01%	1558
2019 Q4	$3.13M	Sell	158,784 -16,850	-10%	-$322K	﹤0.01%	1588
2019 Q3	$3.02M	Hold	175,634	–	–	﹤0.01%	1535
2019 Q2	$3.11M	Sell	175,634 -202,890	-54%	-$3.69M	﹤0.01%	1501
2019 Q1	$7.73M	Buy	+378,524	New	+$7.62M	﹤0.01%	969

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Legal & General Group's TAK Position: Q2 2026 in Review

Legal & General Group held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 43,464 shares worth $697K. The position accounts for ﹤0.01% of the portfolio, ranked #2306.

Legal & General Group first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. The position peaked at $7.73M in Q1 2019. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Legal & General Group held 43,464 shares of Takeda Pharmaceutical worth $697K as of Q2 2026.
Legal & General Group left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2306 holding.
Legal & General Group first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
Legal & General Group's Takeda Pharmaceutical position peaked at $7.73M in Q1 2019.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.